UPDATE 2-United Therapeutics' oral PAH drug fails trial - Reuters

Dividend.com

UPDATE 2-United Therapeutics' oral PAH drug fails trial Reuters - Nov 17, 2008 O: Quote, Profile, Research, Stock Buzz) said a late-stage trial of its experimental oral treatment for pulmonary arterial hypertension (PAH) failed to meet ... Lilly Sells Rights to Tadalafil Inside INdiana Business (press release) Lilly Licenses US Rights for Tadalafil PAH Indication to United ... International Business Times all 80 news articles

Nurses Journal Scan, September 2008 - Medscape (registration)

Nurses Journal Scan, September 2008 Medscape (registration) - 19 hours ago In serious conditions, pediatric sleep apnea may be linked to growth failure, pulmonary hypertension, left and right ventricular hypertrophy, ...

FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial ... - MarketWatch

FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial ... MarketWatch - Nov 17, 2008 announced today the results of the FREEDOM-C trial of oral treprostinil, a sustained-release formulation of treprostinil, in pulmonary arterial hypertension ...

Uncovering the cause of post-stress test distress - Cortlandt Forum

Uncovering the cause of post-stress test distress Cortlandt Forum, NY - Nov 17, 2008 Past medical history included hypercholesterolemia and hypertension with no other significant diagnoses. Ms. K had never smoked cigarettes or used illegal ...

Gilead Announces Two-Year Clinical Data for Letairis(R ... - MarketWatch

Gilead Announces Two-Year Clinical Data for Letairis(R ... MarketWatch - Oct 28, 2008 In addition, there have been post-marketing reports of fluid retention in patients with pulmonary hypertension, occurring within weeks after starting ...